
An analysis of human genetic and biomarker data found that tuberculosis was a risk factor for Behçet disease, a noninfectious uveitis condition.

An analysis of human genetic and biomarker data found that tuberculosis was a risk factor for Behçet disease, a noninfectious uveitis condition.

House Budget Committee advances $1.9 trillion coronavirus disease 2019 (COVID-19) relief bill; FDA will expedite trials examining booster shots against COVID-19 variants; 1 shot of Pfizer/BioNTech's COVID-19 vaccine cuts hospitalization risk by 75%.

Elderly patients who recently had a heart attack and fit the criteria for obstructive sleep apnea were shown to be at greater risk for heart rhythm disorders, such as arrhythmia and coronary artery disease, as well as for major adverse cardiovascular and cerebrovascular events.

Low-quality maternal diets may increase the odds of offspring being considered overweight or obese, according to study results published in BMC Medicine.

Compared with women with normotensive pregnancies, women who develop various hypertensive disorders during pregnancy have a greater risk of cardiac structure abnormalities in the decade after pregnancy.

Pfizer/BioNTech vaccine shown to prevent most coronavirus disease 2019 (COVID-19)–related deaths or hospitalizations; extreme weather delays 6 million vaccine doses; post-traumatic stress disorder and anxiety seen in COVID-19 survivors.

Nicole Neumarker, executive vice president of development and innovation at Cotiviti, discusses the key areas to remember when developing new data models in health care.

The Midwest Business Group on Health's program this week on behavioral health will explore strategies that employers have implemented to address rising anxiety and financial stressors in the workforce amid the coronavirus disease 2019 pandemic.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A German-style fair value/pricing committee may be in the works for the United States. However, government payers still have work to do before implementing a value assessment system.

Health-related quality of life was maintained when treating relapsed/refractory multiple myeloma (RRMM) with daratumumab in combination with bortezomib and dexamethasone.

Multimorbidity affects 1 in 4 US adults and leads to increased health care use and lower quality of life.

Advocates for patients with progressive multiple sclerosis (MS) want changes in study designs on emerging therapies to speed development and better align with the needs of researchers and patients.

Older patients are at greater risk of death in the earliest stages of dialysis, while females possibly are at a higher risk than men, a review of studies found.

Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.

Visual dysfunction among patients with Parkinson disease was associated with worse cognitive performance after 18 months and a higher risk of developing mild cognitive impairment compared with those with normal vision.

Patients with chronic kidney disease (CKD) healthy enough not to have seen a specialist have higher hospitalization rates than the general population, according to a recent study.

The results from an analysis of patients from 12 rheumatology centers treated with secukinumab for psoriatic arthritis were in line with earlier pivotal trials, the researchers said.

The most recent Morbidity and Mortality Weekly Report from the CDC shows there is a great unmet need for earlier intervention for and treatment of HIV among Black Americans living in rural areas.

The current guidance emphasizes that the mRNA-based Pfizer/BioNTech and Moderna vaccines are safe for people with multiple sclerosis (MS) taking disease modifying therapies (DMTs).

As Medicaid is a federated program between states and the federal government, it has historically been difficult for innovation to spread state to state, hindering any comparison of quality metrics.

Gabapentin and baclofen can improve chronic refractory cough caused by gastroesophageal reflux disease, but efficacy is limited and further study needed.

An anxiety screening tool should be included during initial assessments of migraineurs by medical practitioners, according to the authors of a systematic review published in Frontiers in Neurology.

Older adults who reported getting 5 hours or less of sleep per night exhibited a more than 2-fold increased risk of dementia than those who reported 7 to 8 hours of sleep, with sleep disturbance and deficiency additionally linked with overall risk of death.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The Pfizer/BioNTech coronavirus disease 2019 vaccine can be stored at higher temperatures; the Biden administration pledges $4 billion over 2 years to Gavi, the Vaccine Alliance; Medicare payments will soon decrease for hundreds of hospitals.

This week, the top managed care news included Entresto winning the first FDA nod in a hard-to-treat type of heart failure; President Joe Biden nominates a new CMS administrator; experts discuss the potential for Biden health reforms.

Hypertension, anemia, and infection were the most common adverse events associated with mantle cell lymphoma (MCL), while hepatotoxicity, stroke, and renal failure were the costliest per patient.

An article by Willis Towers Watson discusses how employers are supporting their respective workforce amid the pandemic, with education of approved vaccines and effective communication channels with state and local health departments referenced as key actions to be taken at this time.

The SURPASS program, which consists in part of SURPASS-3 and SURPASS-5, is testing the efficacy and safety of tirzepatide, a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
